# Streptococus Pyogenes

## Picibanil inj 5KE

##### 臨採

| TAH Drug Code      | [IPKE5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPKE5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Cancers of the digestive organs, head & neck, thyroid, lung.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | For intravenous injection, starting at 0.2-1 KE 2-3 times weekly; may increase to 1-3 KE 2-3 times weekly as maintenance therapy. For local injection, 5-10 KE dissolved in 2 mL normal saline as a single dose administered locally once daily or once a few days. For administration into the serous cavity, a single dose of 5-10 KE in 2 mL normal saline 2-3 times weekly. For intramuscular or subcutaneous injection, starting at 0.2-0.5 KE in 2 mL normal saline once daily or once every other day. May consider increasing dose gradually after 3-5 doses. Maintenance dose: 1-5 KE 1-3 times weeekly. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | History of anaphylactic reactions to benzylpenicillin. History of previous shock reactions to the drug.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Nausea, vomiting, anorexia; pyrexia, generalized fatigability, headache, arthralgia; pain, swelling at site of inj. Rarely, hypersensitivity reactions, shock, anemia.                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

